Here are 12 gastroenterologists who have recently joined a new practice or opened a new office. Physicians are listed in alphabetical order.
GI & Endoscopy
Bayer HealthCare will seek FDA approval for its new colorectal cancer drug, regorafenib, and if approved, the drug would be the first new drug to treat colorectal cancer in more than five years, according to a Los Angeles Times report.
A new study found using lectins, a naturally occurring protein, labeled with fluorescence highlighted areas of high-grade dysplasia and cancer in the esophagus, according to findings published in Nature Medicine.
Todd McCarty, MD, FACS, of the Lakewood Weight Loss & Wellness Clinic in Dallas, performed the first natural orifice bariatric surgery in November. This minimally invasive procedure involves entering the abdominal cavity through natural openings — in this case, the…
Gut health has implications beyond the gastrointestinal tract, and several new studies are looking at how testing gut health can diagnose and treat other conditions, according to a Wall Street Journal report.
Advertisement
Researchers found weight loss was quicker, greater and retained better after Roux-en-Y gastric bypass than gastric banding surgery, according to findings published in the Archives of Surgery.
Tim Rubin, a gastroenterologist at Essentia Health in Duluth, Minn., will be featured on the nationally syndicated television show "The Doctors" next week for performing fecal transplants, according to a Superior Telegram report.
Zubin Bhesania, MD, and Anthony W. Boutt, MD, have joined the Michigan Bariatric Institute at Saint Joseph Mercy Health System's Saint Joseph Mercy Hospital in Ann Arbor, Mich., according to a SJMHS news release.
A study found that while the long-term risks for recurrent acute diverticulitis are limited after colectomy, medically treated patients have similar outcomes, according to findings published in the British Journal of Surgery.
The FDA's Gastroenterology-Urology Devices Panel voted unanimously that LINX's Reflux Management System, a laparoscopically implanted device designed to treat gastroesophageal reflux disease, has a favorable risk-benefit profile and was safe and effective, according to an FDA report.